Bill Text: TX SB1489 | 2021-2022 | 87th Legislature | Comm Sub
Bill Title: Relating to the provision of information regarding COVID-19 prevention and treatment to individuals receiving a COVID-19 viral test.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Introduced - Dead) 2021-05-20 - Not again placed on intent calendar [SB1489 Detail]
Download: Texas-2021-SB1489-Comm_Sub.html
By: Hall | S.B. No. 1489 | |
(In the Senate - Filed March 10, 2021; March 24, 2021, read | ||
first time and referred to Committee on Health & Human Services; | ||
May 13, 2021, reported adversely, with favorable Committee | ||
Substitute by the following vote: Yeas 5, Nays 4; May 13, 2021, | ||
sent to printer.) | ||
COMMITTEE SUBSTITUTE FOR S.B. No. 1489 | By: Perry |
|
||
|
||
relating to the provision of information regarding COVID-19 | ||
prevention and treatment to individuals receiving a COVID-19 viral | ||
test. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Chapter 81, Health and Safety Code, is amended by | ||
adding Subchapter K to read as follows: | ||
SUBCHAPTER K. COVID-19 TESTING, PREVENTION, AND TREATMENT | ||
Sec. 81.451. DEFINITIONS. In this subchapter: | ||
(1) "COVID-19" means the 2019 novel coronavirus | ||
disease. | ||
(2) "Health care provider" means a person who is | ||
licensed, certified, or otherwise authorized to provide COVID-19 | ||
viral testing. | ||
Sec. 81.452. COVID-19 PREVENTION AND TREATMENT | ||
INFORMATION. The department shall post on the department's | ||
Internet website a printable brochure containing information about | ||
preventative measures and treatments for COVID-19. The brochure | ||
must include the following information: | ||
(1) methods for improving the functioning of an | ||
individual's immune system; | ||
(2) the importance of therapeutic prevention of | ||
COVID-19, including the use of nutraceuticals, the use of | ||
prescription medications, and the benefits and risks associated | ||
with receiving a vaccination; | ||
(3) the importance of seeking treatment for COVID-19 | ||
as soon as symptoms appear and a list of methods for treating | ||
COVID-19 that may be effective, including available medications; | ||
and | ||
(4) advanced home treatments for reducing COVID-19 | ||
symptoms and preventing hospitalization after an individual | ||
contracts COVID-19, including monoclonal antibody therapy. | ||
Sec. 81.453. REQUIREMENTS FOR HEALTH CARE PROVIDERS. A | ||
health care provider that performs a COVID-19 viral test on an | ||
individual shall, at the time the provider performs the test, | ||
provide a printed or electronic copy of the brochure described by | ||
Section 81.452 to the individual receiving the test. | ||
SECTION 2. As soon as practicable after the effective date | ||
of this Act, the Department of State Health Services shall develop | ||
and post on the department's Internet website the brochure required | ||
by Section 81.452, Health and Safety Code, as added by this Act. | ||
SECTION 3. This Act takes effect immediately if it receives | ||
a vote of two-thirds of all the members elected to each house, as | ||
provided by Section 39, Article III, Texas Constitution. If this | ||
Act does not receive the vote necessary for immediate effect, this | ||
Act takes effect September 1, 2021. | ||
* * * * * |